2Mc Millan R,Wang L,Tani P.Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura(ITP)[J].J Thromb Haemost,2003,1(3):485-491. 被引量：1
2Stockelberg D, Houm M, Jacobsson S, et al. Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigencapture ELISA[J]. Eur J Haematol, 1996, 56:72 被引量：1
3Cines D B, Blanchetle V S. Immune thrombocytopenic purpura[J]. New Eng J Med, 2002, 346:995 - 1008. 被引量：1
4Brighton TA, Evans S, Castaldi PA, et al. Prospective evaluation of the clinical usefulness of an antigen-specific assay(MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenics [ J ]. Blood, 1996,88:194 - 201. 被引量：1
4Go RS,Johnston KL,Bruden KC. The association between platelet autoantibody specificity and response to intravenous immunoglobulin G in the treatment of patients with immune thrombocytopenia.Haematologica.2007,Feb;92(2):283-284. 被引量：1
5Zaja F, Battista ML, Pirrotta MT, et al. Lower dose rituximab is ac- tive in adults patients with idiopathic thrombocytopenic purpura [ J ]. Haematologica, 2008,9 ( 93 ) : 930 -933. 被引量：1
6Stasi R, Cooper N, Del Poeta G, et al. Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receive- ing B cell-depleting therapy with rituximab[ J]. Blood ,2008,1 ( 112 ) : 1147-1150. 被引量：1
7MeMillan R. The role of antiplatelet autoantibody assays in the diagnosis of immune thrombocytopenic purpura[J]. Curr Hematol Rep, 2005, 4(2): 160-165. 被引量：1
9Walk J, Westerlaken GH, van Uden NO, et al. Inhibitory receptor expression on neonatal immune cells[J]. Clin Exp Immunol, 2012, 169(2): 164-171. 被引量：1
10Jansen CA, Cruijsen CW, de Ruiter T, et al. Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation[J]. J Immunol, 2007, 37(4): 914-924. 被引量：1
